Knight Therapeutics Future Growth
Future criteria checks 4/6
Knight Therapeutics is forecast to grow earnings and revenue by 58.4% and 8.7% per annum respectively. EPS is expected to grow by 52.3% per annum. Return on equity is forecast to be 3.3% in 3 years.
Key information
58.4%
Earnings growth rate
52.3%
EPS growth rate
| Pharmaceuticals earnings growth | 57.1% |
| Revenue growth rate | 8.7% |
| Future return on equity | 3.3% |
| Analyst coverage | Good |
| Last updated | 30 Apr 2024 |
Recent future growth updates
Recent updates
Does Knight Therapeutics (TSE:GUD) Have A Healthy Balance Sheet?
May 28
Shareholders May Not Be So Generous With Knight Therapeutics Inc.'s (TSE:GUD) CEO Compensation And Here's Why
May 07Calculating The Fair Value Of Knight Therapeutics Inc. (TSE:GUD)
Apr 07Read This Before Selling Knight Therapeutics Inc. (TSE:GUD) Shares
Mar 20If You Had Bought Knight Therapeutics' (TSE:GUD) Shares Three Years Ago You Would Be Down 34%
Mar 02Knight Therapeutics (TSE:GUD) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway
Feb 03
Knight Therapeutics's (TSE:GUD) Earnings Are Growing But Is There More To The Story?
Jan 19What Type Of Shareholders Own The Most Number of Knight Therapeutics Inc. (TSE:GUD) Shares?
Jan 04A Look At The Fair Value Of Knight Therapeutics Inc. (TSE:GUD)
Dec 20The Founder of Knight Therapeutics Inc. (TSE:GUD), Jonathan Goodman, Just Bought A Few More Shares
Dec 07What Type Of Returns Would Knight Therapeutics'(TSE:GUD) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Dec 02Need To Know: The Consensus Just Cut Its Knight Therapeutics Inc. (TSE:GUD) Estimates For 2021
Nov 17Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 387 | 17 | 38 | 50 | 3 |
| 12/31/2025 | 354 | 3 | 30 | 37 | 4 |
| 12/31/2024 | 344 | 4 | 43 | 24 | 6 |
| 12/31/2023 | 328 | -17 | 26 | 36 | N/A |
| 9/30/2023 | 336 | -8 | 5 | 20 | N/A |
| 6/30/2023 | 326 | -16 | 2 | 17 | N/A |
| 3/31/2023 | 312 | -15 | -2 | 31 | N/A |
| 12/31/2022 | 294 | -30 | 19 | 45 | N/A |
| 9/30/2022 | 270 | -23 | 21 | 43 | N/A |
| 6/30/2022 | 271 | -33 | 18 | 42 | N/A |
| 3/31/2022 | 261 | -7 | -183 | 40 | N/A |
| 12/31/2021 | 243 | 16 | -180 | 45 | N/A |
| 9/30/2021 | 240 | 32 | -181 | 44 | N/A |
| 6/30/2021 | 212 | 59 | -195 | 31 | N/A |
| 3/31/2021 | 200 | 47 | 7 | 26 | N/A |
| 12/31/2020 | 200 | 42 | -33 | -12 | N/A |
| 9/30/2020 | 182 | 27 | -27 | -9 | N/A |
| 6/30/2020 | 140 | 6 | -16 | -2 | N/A |
| 3/31/2020 | 90 | 8 | -11 | -7 | N/A |
| 12/31/2019 | 47 | 15 | 2 | 5 | N/A |
| 9/30/2019 | 14 | 21 | -3 | 0 | N/A |
| 6/30/2019 | 13 | 37 | -26 | -24 | N/A |
| 3/31/2019 | 12 | 22 | -25 | -22 | N/A |
| 12/31/2018 | 13 | 24 | -10 | -6 | N/A |
| 9/30/2018 | 11 | 31 | -7 | -4 | N/A |
| 6/30/2018 | 10 | 22 | 24 | 27 | N/A |
| 3/31/2018 | 10 | 18 | 23 | 26 | N/A |
| 12/31/2017 | 9 | 17 | 23 | 23 | N/A |
| 9/30/2017 | 8 | 18 | N/A | 21 | N/A |
| 6/30/2017 | 8 | 20 | N/A | 15 | N/A |
| 3/31/2017 | 7 | 24 | N/A | 14 | N/A |
| 12/31/2016 | 6 | 19 | N/A | 15 | N/A |
| 9/30/2016 | 4 | 16 | N/A | 24 | N/A |
| 6/30/2016 | 3 | 17 | N/A | 19 | N/A |
| 3/31/2016 | 2 | 21 | N/A | 15 | N/A |
| 12/31/2015 | 1 | 34 | N/A | 10 | N/A |
| 9/30/2015 | 1 | 154 | N/A | -2 | N/A |
| 6/30/2015 | 1 | 148 | N/A | -1 | N/A |
| 3/31/2015 | 1 | 140 | N/A | 0 | N/A |
| 12/31/2014 | 0 | 126 | N/A | 1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GUD is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.1%).
Earnings vs Market: GUD is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: GUD is expected to become profitable in the next 3 years.
Revenue vs Market: GUD's revenue (8.7% per year) is forecast to grow faster than the Canadian market (6.7% per year).
High Growth Revenue: GUD's revenue (8.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: GUD's Return on Equity is forecast to be low in 3 years time (3.3%).